Selected research
Market Structure
Global Molecular Pathology Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Molecular Pathology Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Molecular Pathology Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Molecular Pathology Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Molecular Pathology Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Molecular Pathology Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Molecular Pathology Services include Quest Diagnostics, Labcorp, Sonic Healthcare, NeoGenomics, Foundation Medicine, Caris Life Sciences, Tempus, Guardant Health and Exact Sciences, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Molecular Pathology Services market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Molecular Pathology Services and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Molecular Pathology Services revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Molecular Pathology Services market size, projected growth trends, production technologies, key applications, and end-use industries.
Molecular Pathology Services Segment by Company
Quest Diagnostics
Labcorp
Sonic Healthcare
NeoGenomics
Foundation Medicine
Caris Life Sciences
Tempus
Guardant Health
Exact Sciences
Eurofins
Unilabs
Molecular Pathology Services Segment by Type
Solid Tumor Molecular Pathology Services
Hematologic Malignancy Molecular Pathology Services
Hereditary Disease Molecular Pathology Services
Infectious Disease Molecular Testing Services
Rare Disease Molecular Pathology Services
Others
Molecular Pathology Services Segment by Application
Hospitals and Medical Centers
Independent Clinical Laboratories
Academic and Research Institutes
Biopharmaceutical Companies
Others
Molecular Pathology Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Molecular Pathology Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Molecular Pathology Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Molecular Pathology Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Molecular Pathology Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Molecular Pathology Services industry.
Chapter 3: Detailed analysis of Molecular Pathology Services companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Molecular Pathology Servicesrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Solid Tumor Molecular Pathology Services
- Hematologic Malignancy Molecular Pathology Services
- Hereditary Disease Molecular Pathology Services
- Infectious Disease Molecular Testing Services
- Rare Disease Molecular Pathology Services
- Others
Applications
- Hospitals and Medical Centers
- Independent Clinical Laboratories
- Academic and Research Institutes
- Biopharmaceutical Companies
- Others
Companies covered
- Quest Diagnostics
- Labcorp
- Sonic Healthcare
- NeoGenomics
- Foundation Medicine
- Caris Life Sciences
- Tempus
- Guardant Health
- Exact Sciences
- Eurofins
- Unilabs
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Molecular Pathology Services Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Solid Tumor Molecular Pathology Services
- 1.2.3 Hematologic Malignancy Molecular Pathology Services
- 1.2.4 Hereditary Disease Molecular Pathology Services
- 1.2.5 Infectious Disease Molecular Testing Services
- 1.2.6 Rare Disease Molecular Pathology Services
- 1.2.7 Others
- 1.3 Market Analysis by Application
- 1.3.1 Global Molecular Pathology Services Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Hospitals and Medical Centers
- 1.3.3 Independent Clinical Laboratories
- 1.3.4 Academic and Research Institutes
- 1.3.5 Biopharmaceutical Companies
- 1.3.6 Others
- 1.4 Global Market Growth Prospects
- 1.5 Global Molecular Pathology Services Growth Trends by Region
- 1.5.1 Global Molecular Pathology Services Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Molecular Pathology Services Market Size by Region (2021-2026)
- 1.5.3 Molecular Pathology Services Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Molecular Pathology Services Market Dynamics
- 2.1 Molecular Pathology Services Industry Trends
- 2.2 Molecular Pathology Services Industry Drivers
- 2.3 Molecular Pathology Services Industry Opportunities and Challenges
- 2.4 Molecular Pathology Services Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Molecular Pathology Services Revenue by Company (2021-2026)
- 3.2 Global Molecular Pathology Services Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Molecular Pathology Services Key Company Head office and Area Served
- 3.4 Global Molecular Pathology Services Company, Product Type & Application
- 3.5 Global Molecular Pathology Services Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Molecular Pathology Services Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Molecular Pathology Services Players Market Share by Revenue in 2025
- 3.6.3 2025 Molecular Pathology Services Tier 1, Tier 2, and Tier 3
4 Molecular Pathology Services Market by Type
- 4.1 Global Molecular Pathology Services Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Molecular Pathology Services Market Size by Type (2021-2032)
- 4.3 Global Molecular Pathology Services Market Size Share by Type (2021-2032)
5 Molecular Pathology Services Market by Application
- 5.1 Global Molecular Pathology Services Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Molecular Pathology Services Market Size by Application (2021-2032)
- 5.3 Global Molecular Pathology Services Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Quest Diagnostics
- 6.1.1 Quest Diagnostics Company Information
- 6.1.2 Quest Diagnostics Business Overview
- 6.1.3 Quest Diagnostics Molecular Pathology Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Quest Diagnostics Molecular Pathology Services Product Portfolio
- 6.1.5 Quest Diagnostics Recent Developments
- 6.2 Labcorp
- 6.2.1 Labcorp Company Information
- 6.2.2 Labcorp Business Overview
- 6.2.3 Labcorp Molecular Pathology Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Labcorp Molecular Pathology Services Product Portfolio
- 6.2.5 Labcorp Recent Developments
- 6.3 Sonic Healthcare
- 6.3.1 Sonic Healthcare Company Information
- 6.3.2 Sonic Healthcare Business Overview
- 6.3.3 Sonic Healthcare Molecular Pathology Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Sonic Healthcare Molecular Pathology Services Product Portfolio
- 6.3.5 Sonic Healthcare Recent Developments
- 6.4 NeoGenomics
- 6.4.1 NeoGenomics Company Information
- 6.4.2 NeoGenomics Business Overview
- 6.4.3 NeoGenomics Molecular Pathology Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 NeoGenomics Molecular Pathology Services Product Portfolio
- 6.4.5 NeoGenomics Recent Developments
- 6.5 Foundation Medicine
- 6.5.1 Foundation Medicine Company Information
- 6.5.2 Foundation Medicine Business Overview
- 6.5.3 Foundation Medicine Molecular Pathology Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Foundation Medicine Molecular Pathology Services Product Portfolio
- 6.5.5 Foundation Medicine Recent Developments
- 6.6 Caris Life Sciences
- 6.6.1 Caris Life Sciences Company Information
- 6.6.2 Caris Life Sciences Business Overview
- 6.6.3 Caris Life Sciences Molecular Pathology Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Caris Life Sciences Molecular Pathology Services Product Portfolio
- 6.6.5 Caris Life Sciences Recent Developments
- 6.7 Tempus
- 6.7.1 Tempus Company Information
- 6.7.2 Tempus Business Overview
- 6.7.3 Tempus Molecular Pathology Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Tempus Molecular Pathology Services Product Portfolio
- 6.7.5 Tempus Recent Developments
- 6.8 Guardant Health
- 6.8.1 Guardant Health Company Information
- 6.8.2 Guardant Health Business Overview
- 6.8.3 Guardant Health Molecular Pathology Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Guardant Health Molecular Pathology Services Product Portfolio
- 6.8.5 Guardant Health Recent Developments
- 6.9 Exact Sciences
- 6.9.1 Exact Sciences Company Information
- 6.9.2 Exact Sciences Business Overview
- 6.9.3 Exact Sciences Molecular Pathology Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Exact Sciences Molecular Pathology Services Product Portfolio
- 6.9.5 Exact Sciences Recent Developments
- 6.10 Eurofins
- 6.10.1 Eurofins Company Information
- 6.10.2 Eurofins Business Overview
- 6.10.3 Eurofins Molecular Pathology Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Eurofins Molecular Pathology Services Product Portfolio
- 6.10.5 Eurofins Recent Developments
- 6.11 Unilabs
- 6.11.1 Unilabs Company Information
- 6.11.2 Unilabs Business Overview
- 6.11.3 Unilabs Molecular Pathology Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Unilabs Molecular Pathology Services Product Portfolio
- 6.11.5 Unilabs Recent Developments
7 North America
- 7.1 North America Molecular Pathology Services Market Size (2021-2032)
- 7.2 North America Molecular Pathology Services Market Size by Type
- 7.2.1 North America Molecular Pathology Services Market Size by Type (2021-2026)
- 7.2.2 North America Molecular Pathology Services Market Size by Type (2027-2032)
- 7.2.3 North America Molecular Pathology Services Market Share by Type (2021-2032)
- 7.3 North America Molecular Pathology Services Market Size by Application
- 7.3.1 North America Molecular Pathology Services Market Size by Application (2021-2026)
- 7.3.2 North America Molecular Pathology Services Market Size by Application (2027-2032)
- 7.3.3 North America Molecular Pathology Services Market Share by Application (2021-2032)
- 7.4 North America Molecular Pathology Services Market Size by Country
- 7.4.1 North America Molecular Pathology Services Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Molecular Pathology Services Market Size by Country (2021-2026)
- 7.4.3 North America Molecular Pathology Services Market Size by Country (2027-2032)
- 7.4.4 North America Molecular Pathology Services Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Molecular Pathology Services Market Size (2021-2032)
- 8.2 Europe Molecular Pathology Services Market Size by Type
- 8.2.1 Europe Molecular Pathology Services Market Size by Type (2021-2026)
- 8.2.2 Europe Molecular Pathology Services Market Size by Type (2027-2032)
- 8.2.3 Europe Molecular Pathology Services Market Share by Type (2021-2032)
- 8.3 Europe Molecular Pathology Services Market Size by Application
- 8.3.1 Europe Molecular Pathology Services Market Size by Application (2021-2026)
- 8.3.2 Europe Molecular Pathology Services Market Size by Application (2027-2032)
- 8.3.3 Europe Molecular Pathology Services Market Share by Application (2021-2032)
- 8.4 Europe Molecular Pathology Services Market Size by Country
- 8.4.1 Europe Molecular Pathology Services Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Molecular Pathology Services Market Size by Country (2021-2026)
- 8.4.3 Europe Molecular Pathology Services Market Size by Country (2027-2032)
- 8.4.4 Europe Molecular Pathology Services Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Molecular Pathology Services Market Size (2021-2032)
- 9.2 China Molecular Pathology Services Market Size by Type
- 9.2.1 China Molecular Pathology Services Market Size by Type (2021-2026)
- 9.2.2 China Molecular Pathology Services Market Size by Type (2027-2032)
- 9.2.3 China Molecular Pathology Services Market Share by Type (2021-2032)
- 9.3 China Molecular Pathology Services Market Size by Application
- 9.3.1 China Molecular Pathology Services Market Size by Application (2021-2026)
- 9.3.2 China Molecular Pathology Services Market Size by Application (2027-2032)
- 9.3.3 China Molecular Pathology Services Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Molecular Pathology Services Market Size (2021-2032)
- 10.2 Asia Molecular Pathology Services Market Size by Type
- 10.2.1 Asia Molecular Pathology Services Market Size by Type (2021-2026)
- 10.2.2 Asia Molecular Pathology Services Market Size by Type (2027-2032)
- 10.2.3 Asia Molecular Pathology Services Market Share by Type (2021-2032)
- 10.3 Asia Molecular Pathology Services Market Size by Application
- 10.3.1 Asia Molecular Pathology Services Market Size by Application (2021-2026)
- 10.3.2 Asia Molecular Pathology Services Market Size by Application (2027-2032)
- 10.3.3 Asia Molecular Pathology Services Market Share by Application (2021-2032)
- 10.4 Asia Molecular Pathology Services Market Size by Country
- 10.4.1 Asia Molecular Pathology Services Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Molecular Pathology Services Market Size by Country (2021-2026)
- 10.4.3 Asia Molecular Pathology Services Market Size by Country (2027-2032)
- 10.4.4 Asia Molecular Pathology Services Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Molecular Pathology Services Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Molecular Pathology Services Market Size by Type
- 11.2.1 South America, Middle East & Africa Molecular Pathology Services Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Molecular Pathology Services Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Molecular Pathology Services Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Molecular Pathology Services Market Size by Application
- 11.3.1 South America, Middle East & Africa Molecular Pathology Services Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Molecular Pathology Services Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Molecular Pathology Services Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Molecular Pathology Services Market Size by Country
- 11.4.1 South America, Middle East & Africa Molecular Pathology Services Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Molecular Pathology Services Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Molecular Pathology Services Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Molecular Pathology Services Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst